Kerry Kinney, Cockrell School of EngineeringĪtila Novoselac, Cockrell School of Engineering Tanya Hutter, Cockrell School of Engineering Pawel Misztal, Cockrell School of Engineering Jason McLellan, College of Natural SciencesĪ study to identify high-affinity antibodies to the COVID-19 spike protein that can be used in post-care diagnostics with saliva samples, creating materials needed for a rapid point-of-care diagnostic that can be done in the lab or with a modified iPhone.ĭevelopment of a novel, non-invasive and rapid breath test to detect COVID-19 infections in real time, utilizing UT Austin’s state-of-the-art chemical ionization mass spectrometer. Ilya Finkelstein, College of Natural Sciences Jennifer Maynard, Cockrell School of Engineering Jessica Podnar, Vice President for ResearchĪ project to engineer the SARS-CoV-2 spike protein - one of the key targets for effective therapy - to improve manufacturing and stability for improved vaccines and diagnostics. Jason Lavinder, Cockrell School of Engineering Gregory Ippolito, College of Natural SciencesĮdward Marcotte, College of Natural SciencesĬhris Sullivan, College of Natural Sciences Jimmy Gollihar, College of Natural Sciences Joydeep Ghosh, Cockrell School of Engineeringĭevelopment of a remote, home-monitoring system for individuals diagnosed with COVID-19 that provides the tools for early identification and intervention for those needing an escalation in care without risking widespread exposure.ĭevelopment of a rapid blood-based assay that detects viral biomarkers to predict a patient’s vulnerability and response to treatment of COVID-19, supporting clinical decision-making on optimal treatment.Īlan Lambowitz, College of Natural Sciencesĭevelopment of novel viral RNA and serological testing methodology to provide COVID-19 infection monitoring for health care workers, limiting the spread and impact of the pandemic.Īndreas Matouschek, College of Natural SciencesĪndrew Ellington, College of Natural Sciences Livia Schiavinato Eberlin, College of Natural SciencesĪpplication of newly discovered, high-throughput phenotyping methods to better predict wildly variable differences in patient vulnerability and outcomes, helping to predict infection progression, facilitate customized patient care, improve health outcomes and reduce the load on medical staff and equipment. Your support will advance our research efforts to fight COVID-19 now and help minimize or prevent future outbreaks.Īdaptation of the pioneering MasSpec Pen technology, which broke new ground in the rapid diagnosis of cancer, for direct, hand-held, rapid sampling and analysis of COVID-19.